Physician profile
John W Tyrone
NPI 1063458768
$60,694.41
in general payments reported to CMS, 2019-2025
11 companies · $2,790 in 2025
The $2,790 reported for 2025 was more than what 88% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,683 · 2020: $480 · 2021: $36K · 2022: $7,284 · 2023: $2,662 · 2024: $2,736 · 2025: $2,790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,589 · Food and Beverage: $1,582 · Education: $16.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,589.40 |
| Food and Beverage | $1,581.91 |
| Education | $16.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $51,775.48 | 2019-2022 | |
| Abbvie INC. | $7,545.80 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Merz North America, INC. | $411.69 | 2019-2022 | |
| Revance Therapeutics, INC. | $385.37 | 2024 | Daxxify |
| Bard Peripheral Vascular, INC. | $144.24 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $107.63 | 2021-2022 | |
| Motiva USA, LLC | $86.04 | 2024-2025 | |
| Galderma Laboratories, L.P. | $80.93 | 2019-2025 | |
| Integra Lifesciences Corporation | $66.40 | 2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Tela Bio, INC. | $51.00 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sanara Medtech INC. | $39.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tyrone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.